Results

Total Results: 743 records

Showing results for "continuing".

1. Procedure Manual Appendix II: USPSTF Conflict of Interest Disclosure Form | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-ii-uspstf-conflict-interest-disclosure-form
   July 01, 2017 - interests for your immediate family members and close personal relationships related to all new and continuing … topics in development, as well as any changes in my situation since this form was last completed for continuing … topics in development, as well as any changes in my situation since this form was last completed for continuing

2. Screening for Hepatitis B Virus (HBV) Infection in Pregnancy: Clinical Summary (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/7zPpSv5ZBsqCJttG9r7HQ3
   June 01, 2009 - Re-screen women with unknown HBsAg status or new or continuing risk factors at admission to hospital

3. Clinical Summary: Screening for Hepatitis B Virus Infection in Pregnant Women (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/u7yLAN-SqsWk4TSoj-VH7V
   Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection

4. Clinical Summary: US Preventive Services Task Force Recommendations on Screening for Chlamydial Infection (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/LSQD6GNttH3e6QaZ6NBzY3
   July 17, 2007 - For patients at continuing risk, or who are newly at risk: Screen in the 3rd trimester.

5. Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/folic-acid-suppl-draft-rec-bulletin.pdf
   March 20, 2023 - “The best time to start taking folic acid is at least one month before pregnancy and continuing through

6. Archived: Hepatitis B in Pregnant Women: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-in-pregnant-women-screening-2009
   June 15, 2009 - Re-screen women with unknown HBsAg status or new or continuing risk factors at admission to hospital, … a hospital, birth center, or other delivery setting, women with unknown HBsAg status or with new or continuing

7. USPSTF Clinician Summary of USPSTF Recommendation: Screening for Latent Tuberculosis Infection in Adults (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/nV4GCeHGsZrfKUWxo9_zZb
   April 01, 2023 - • In addition, the CDC maintains several resources and continuing education activities on LTBI for

8. Task Force Issues Final Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects: Taking folic acid before and during early pregnancy helps prevent neural tube defects (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/folic-acid-suppl-final-rec-bulletin.pdf
   August 01, 2023 - “Folic acid is most beneficial when taken at least one month before pregnancy and continuing through

9. Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/lets-talk-about-it-aspirin-cvd-prevention-guide.pdf
   April 26, 2022 - However, data suggests that for those eligible to start taking aspirin, continuing into one’s early

10. Screening for Hepatitis B Virus Infection in Pregnancy: Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ykFSVS29KAwKzFWSXAVoMY
    June 01, 2009 - hospital, birth center, or other de- livery setting, women with unknown HBsAg status or with new or continuing … R escreen w om en w ith unknow n H BsA g status or new or continuing risk factors at adm ission

11. Task Force Issues Final Recommendation Statement on Screening for Breast Cancer: All women should be screened every other year starting at age 40; more research still needed in key areas (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breast-cancer-screening-final-rec-bulletin.pdf
    April 30, 2024 - now recommends that all women get screened for breast cancer every other year starting at age 40 and continuing

12. Frequently Asked Questions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/faqs/final-faq-document/breast-cancer-screening
    April 30, 2024 - Force recommends that all women get screened for breast cancer every other year, starting at age 40 and continuing

13. Archived: Folic Acid/Folate Prophylaxis to Prevent Neural Tube Defects: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-prevent-neural-tube-defects-preventive-medication-1996
    January 01, 1996 - supplement containing folic acid at a dose of 0.4-0.8 mg, beginning at least 1 month prior to conception and continuing … women Folic acid supplementation at a dose of 4 mg/day beginning 1-3 months prior to conception and continuing … offered treatment with 4 mg of folic acid daily starting 1-3 months prior to planned conception and continuing … Folic acid supplementation at a dose of 4 mg/day beginning 1-3 months prior to conception and continuing … supplement containing folic acid at a dose of 0.4-0.8 mg, beginning at least 1 month prior to conception and continuing

14. Behavioral Interventions to Promote Breastfeeding - Recommendations and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/rdNAq7uEUC2tNYV6_L9Qte
    January 01, 2010 - in-person visits or telephone contacts with providers or counselors, increased the proportion of women continuing … of mothers initiating breastfeeding (risk difference 23%; 95% confidence interval [CI], 12–34) and continuing

15. Recommendation: Hepatitis B Virus Infection in Pregnant Women: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-in-pregnant-women-screening
    July 23, 2019 - Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection … Women with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection

16. Screening for Hepatitis B Virus Infection: A Brief Evidence Update (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/StNCYDfuKfxc2LpwtaN8et
    February 01, 2004 - Services. 2 Screening for Hepatitis B Virus Infection: Brief Evidence Update current practice of continuing

17. Archived: Screening and Interventions for Childhood Obesity: Where Is the Evidence? A Commentary by the Childhood Obesity Working Group of the U.S. Preventive Services Task Force: Obesity in Children and Adolescents: Screening, July 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/screening-and-interventions-for-childhood-obesity-where-is-t/obesity-in-children-and-adolescents-screening-2005
    July 11, 2005 - reduced self-esteem, poor eating habits, eating disorders, adverse family relations, or the effects of continuing

18. Archived: Final Evidence Review: Hepatitis B Virus Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review46/hepatitis-b-virus-infection-screening-2004
    February 15, 2004 - New evidence supports current practice of continuing to immunize such infants with HBV vaccine and hepatitis

19. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - of raloxifene, the Multiple Outcomes of Raloxifene Evaluation (MORE) with long-term follow-up in the Continuing … Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women … Siris ES, Harris ST, Eastell R, et al; Continuing Outcomes Relevant to Evista (CORE) Investigators. … Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista … CORE indicates Continuing Outcomes Relevant to Evista; HOT, Hormone replaced therapy Opposed by low-dose

20. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Initiating aspirin use during ages 50 to 59 years and continuing unless contraindicated by an adverse … Initiating aspirin use during ages 60 to 69 years and continuing unless contraindicated by an adverse … Many comments requested clarification about initiating and continuing aspirin use, especially for persons … its focus on initiating aspirin use and enhanced the Implementation section to provide guidance on continuing